Logo

MWG Biotech Shutters Array Business, Sells Lab Automation Unit to Aviso

Feb 04, 2005

NEW YORK, Jan. 4 (GenomeWeb News) - MWG Biotech has sold its lab automation business, including its Theonyx liquid-handling platform, to Greiz, Germany-based Aviso GmbH, the company said today.

 

The Ebersberg, Germany-based company also confirmed that it shuttered its microarray business at the end of December. MWG said in a statement that it is "still interested in selling certain assets of this business unit."

 

MWG announced its intention to exit the automation and array businesses last October.

 

Aviso GmbH will take over MWG Biotech's line of robotics as well as 15 of the company's former lab automation employees. All servicing and warranty services will be continued by Aviso GmbH.

 

Financial details of the sale were not disclosed.

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.